We would love to hear your thoughts about our site and services, please take our survey here.
Royalties are the best option to bring in much higher revenues,
Our tech will be in very high demand globally, expect many many new contracts in all areas. Gla
Any of these?
Something big as they stated it’s a leading global provider of antibodies.
https://blog.citeab.com/who-are-the-leading-research-antibody-market-suppliers/
Any ideas who the company is that’s a leading global supplier of antibodies.
The royalties from this could be worth 10s of millions if global demand is achieved.
Definitely hard to buy any sizeable stock,
Only a matter of time before this sp moves .
Bargain price down here.
The upside from this level is huge, great new today and I expect plenty of news flow coming through in the coming weeks /months.
4m mkcap is a giveaway.
Value will start to show soon enough,
Atb.
Excellent news,
This technology is worth an absolute fortune for the company,
What a great turnaround,,
Ready for a good recovery as FAB has diversified into so many areas of interest and with huge potential also.
I also like the fact that we’ve move into the veterinary sector where there’s an amazing opportunity to increase revenue massively.
Also to be partners with the NCI is a huge milestone for the company and should bring FAB into the limelight’
Just about to begin here.
Mitchell Ho, Ph.D., Deputy Chief, Laboratory of Molecular Biology and Director of the Antibody Engineering Program, Center for Cancer Research, NCI commented: " NCI will test the OptiMAL (R) platform for the discovery of novel antibodies to cancer targets and also SARS-CoV-2. We have a particular interest in Mammalian Cell Display as a discovery engine and look forward to using this in NCI."
Richard Buick, CSO of Fusion, commented: " The expertise and experience of Dr. Ho and his colleagues make NCI an ideal partner for validation of the Optimal (R) library and mammalian cell display technology. I look forward to the collaboration and working closely with the National Cancer Institute."
Totally agree,
Just have to sit back and wait for the news flow to come through.
Added another 50k,
Make the most of these cheap shares.
Atb
Definitely the volume has picked up a lot just lately,
I’m very confident in this company and after a disappointing 2023, it looks like 2024 is going to be a very lucrative year for the company.
Watch this space.
Good to be in here.
Mkcap only 4m , this will move very fast on the next news as so many things going on in the background,
This year will see revenues flying in and so will the sp.
Interesting and very positive investors conference.
https://www.google.com/search?q=proactive+investor+fusion+antibodies+plc&ie=UTF-8&oe=UTF-8&hl=en-gb&client=safari#fpstate=ive&vld=cid:14b5e405,vid:IAvbf90GgvQ,st:0
Looking good now for a move up,
Well oversold and now very very cheap.
Buy.
Yeah,
Bargain price.
Just bought a 200k
L2 looking like a bounce up,
I see this news as a good way forward and doesn’t justify this drop.
Totally agree,
It’s going to be big.
I expecting a good day, so undervalued that I can’t buy enough of these.
Very positive encouraging outlook from the proactive one to one investor conference.
https://www.google.com/search?q=proactive+investor+fusion+antibodies+plc&ie=UTF-8&oe=UTF-8&hl=en-gb&client=safari#fpstate=ive&vld=cid:14b5e405,vid:IAvbf90GgvQ,st:0
Excellent,
A lot of cash coming our way
Should keep going up from here as revenue is increasing and we’re fully funded.
Our US partner is a huge milestone for the company.
Great buy at this level.
Due a good rise,
agree should multibag soon